2203 related articles for article (PubMed ID: 9209487)
1. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
2. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
[TBL] [Abstract][Full Text] [Related]
3. Stochastic acquisition of Qa1 receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets.
Toomey JA; Salcedo M; Cotterill LA; Millrain MM; Chrzanowska-Lightowlers Z; Lawry J; Fraser K; Gays F; Robinson JH; Shrestha S; Dyson PJ; Brooks CG
J Immunol; 1999 Sep; 163(6):3176-84. PubMed ID: 10477585
[TBL] [Abstract][Full Text] [Related]
4. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
[TBL] [Abstract][Full Text] [Related]
5. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
6. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
[TBL] [Abstract][Full Text] [Related]
8. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
9. Participation of the CD94 receptor complex in costimulation of human natural killer cells.
Voss SD; Daley J; Ritz J; Robertson MJ
J Immunol; 1998 Feb; 160(4):1618-26. PubMed ID: 9469418
[TBL] [Abstract][Full Text] [Related]
10. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
[TBL] [Abstract][Full Text] [Related]
11. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
[TBL] [Abstract][Full Text] [Related]
12. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
[TBL] [Abstract][Full Text] [Related]
13. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.
Sivori S; Vitale M; Bottino C; Marcenaro E; Sanseverino L; Parolini S; Moretta L; Moretta A
Eur J Immunol; 1996 Oct; 26(10):2487-92. PubMed ID: 8898964
[TBL] [Abstract][Full Text] [Related]
14. Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes.
Van Beneden K; De Creus A; Stevenaert F; Debacker V; Plum J; Leclercq G
J Immunol; 2002 Apr; 168(7):3295-302. PubMed ID: 11907085
[TBL] [Abstract][Full Text] [Related]
15. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
Söderström K; Corliss B; Lanier LL; Phillips JH
J Immunol; 1997 Aug; 159(3):1072-5. PubMed ID: 9233599
[TBL] [Abstract][Full Text] [Related]
16. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD94 and NKG2 molecules on human CD4(+) T cells in response to CD3-mediated stimulation.
Romero P; Ortega C; Palma A; Molina IJ; Peña J; Santamaría M
J Leukoc Biol; 2001 Aug; 70(2):219-24. PubMed ID: 11493613
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell recognition of HLA class I molecules.
Brooks AG; Boyington JC; Sun PD
Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
[TBL] [Abstract][Full Text] [Related]
20. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
